• About us
  • People
  • Expertise
    • Sectors
        • Technology, media & communications Technology, media & communications
        • Private Wealth Private wealth
        • Real estate, infrastructure & energy
        • Life sciences & healthcare icon Life sciences & healthcare
        • Aerospace & defence
        • Automotive & mobility
        • Business & professional services
        • Chemicals
        • Consumer & retail
        • Financial institutions & insurance
        • Hotels, hospitality & leisure
        • Logistics & transport
        • Manufacturing & industrials
        • Public services & education
    • Legal services
        • Artificial intelligence
        • Banking & finance
        • Brands & advertising
        • Commercial & consumer contracts
        • Competition, EU & trade
        • Copyright & media law
        • Corporate crime & compliance
        • Corporate/M&A & capital markets
        • Data & cyber
        • Disputes & investigations
        • Employment, pensions & mobility
        • Environmental, planning & regulatory
        • Environmental, social & governance (ESG)
        • Information technology
        • Multi-service
        • Patents & innovation
        • Private client
        • Private equity
        • Projects, energy & infrastructure
        • Real estate & construction
        • Regulation
        • Restructuring & insolvency
        • Tax
        • Venture capital
  • Locations
    • Europe
        • Locations
        • Austria
        • Belgium
        • Czech Republic
        • France
        • Germany
        • Hungary
        • Italy
        • Netherlands
        • Poland
        • Portugal
        • Ireland
        • Slovakia
        • Spain
        • United Kingdom
        • Ukraine
          Groups & regions
        • CEE Turkish Desk
        • French German group
        • Our offices
    • Middle East & Africa
        • Locations
        • Middle East
        • UAE
          Groups
        • Africa group
        • Israel group
        • Our offices
    • Americas
        • Locations
        • Latin America
        • USA
          Groups
        • Brazil group
        • Our offices
    • Asia
        • Locations
        • Asia
        • China
        • South Korea
          Groups
        • India group
        • Japan group
        • Our offices
  • Insights
    • Insights
        • Featured Topics
        • Artificial intelligence
        • Data Centre Expertise
        • The EU Whistleblower Directive
        • German Supply Chain Act
        • Unified Patent Court
          Content hub
        • Global Data Hub
        • Interface: tech, IP and media law
        • Podcasts
        • Synapse
        • Browse All Insights
    • Events
        • In person
        • Online
        • Browse All Events
    • News
        • Media centre
        • Work highlights
        • Firm news
        • Browse all news
  • Careers
  • EN
    • English
    • 中文(简体)
    • Français
    • Deutsch
  • Home
  • People
  • Simon Cohen
Simon Cohen
Simon Cohen

Simon Cohen

Partner

  • London UK
Contact Me Today
+44 20 7300 4815
vCard
Email me Call me
Featured award

Managing Intellectual Property – IP Stars 2024

Patent star

Scroll to featured award

Simon is recognised as an outstanding patent litigator with a top-tier practice advising global life sciences companies. Simon specialises in contentious patent work in a variety of industries, but in particular for the life sciences sector. He's also highly experienced in pharmaceutical regulatory work.

Simon represents clients in the UK Patents Court, the UK Court of Appeal and at the European Patent Office, and regularly co-operates with lawyers conducting parallel litigation in the US and other European jurisdictions. He advises pharmaceutical clients on patent infringement and validity, launch strategy, preliminary injunction applications and pharmaceutical regulatory work. Outside of law, Simon lectures and writes regularly and is the UK correspondent of the Bioscience Law Review and the UK Contributor to Pharmaceutical, Biotechnology and Chemical Inventions (published by Oxford University Press).

Expertise

Services and Groups

Patents & innovation
Resolving patents & know-how disputes
Israel group

Sectors

Life sciences & healthcare
Medical devices
Pharmaceuticals
Biotech

CV

Since 1996 Partner, Taylor Wessing
1990 Admitted as lawyer, England & Wales
1984 BSc Biochemistry & Genetics, London University
1992 Diploma in Intellectual Property Law, London University

Career

Since 1996 Partner, Taylor Wessing

Education

1990 Admitted as lawyer, England & Wales
1984 BSc Biochemistry & Genetics, London University
1992 Diploma in Intellectual Property Law, London University

Publications

Instructing Experts in Patent Litigation, co-author with Paul England, Bio-Science Law Review, Vol 13 Issue 5, 2013

Awards

Managing Intellectual Property – IP Stars 2024

Featured

Patent star

Chambers and Partners UK 2024

Intellectual property patent litigation - Band 3: “Simon Cohen is experienced and very good at coordinating.”

Chambers and Partners UK 2023

Life Sciences (IP/patent litigation) - Band 2: Simon Cohen is commended for his deft handling of patent revocation and SPC disputes. He regularly advises on and coordinates pan-European litigation strategies. "Simon Cohen is very thoughtful and clever."

Chambers and Partners UK 2023

Intellectual Property (patent litigation) - Band 3: Simon Cohen is highly regarded for his experience litigating patent disputes for life sciences companies. He is qualified to litigate before UK and European courts.

Life Sciences - IP/Patent Litigation: "Simon Cohen is commended for his deft handling of patent revocation and SPC disputes. He regularly advises on and coordinates pan-European litigation strategies."

Intellectual Property - Patent Litigation: "Simon Cohen is highly regarded for his experience litigating patent disputes for life sciences companies. He is qualified to litigate before UK and European courts."

IP - contentious and non-contentious

Leading individual - Life Sciences: IP/Patent litigation (Band 2): Simon Cohen is commended for his deft handling of patent revocation and SPC disputes. He regularly advises on and co-ordinates pan-European litigation strategies.

Leading individual - Intellectual Property: Patent litigation (Band 2): Simon Cohen is highly regarded for his experience litigating patent disputes for life sciences companies. He is qualified to litigate before UK and European courts.

Leading individual: litigation (Silver): Simon Cohen is “a fantastic professional, deeply strategic and familiar with how to put a great case together”. He is especially sought out for life sciences briefs.

Leading individual: Patents

Patent star

Leading individual - Intellectual Property: Patent Litigation (Band 2): Simon Cohen is a patent litigator with an enviable record running multi-jurisdictional disputes for life sciences companies. A source says he is "great fun to work with - he's relaxed and on top of the detail."

Leading individual - Life Sciences: IP/Patent Litigation (Band 2): Applauded for his "considerable life sciences experience," Simon Cohen is highly regarded for handling complex patent disputes. He is also noted for his pharmaceutical regulatory advice. Sources say he is "great fun to work with, relaxed and on top of the detail."

Leading individual - Intellectual Property: Patent Litigation (Band 2): Simon Cohen acts for leading life sciences companies in complex patent litigation. A market source says: "He is a really good planner and runs his team well."

Leading individual - Life Sciences: IP/Patent Litigation (Band 2): Simon Cohen is best known for co-ordinating complex patent disputes, although he also advises companies on securing market access for their treatments. A source says: "He has played strategic roles in cases covering every aspect of patent litigation and is a really good planner and organiser."

Experience

Apotex's EUR74m sale of subsidiaries to Aurobindo

Apotex on the sale of six European subsidiaries in Belgium, Poland, the Netherlands, Czech Republic and Spain, to Aurobindo for EUR74 million. This highly complex transaction involved the share transfer of subsidiaries in multiple jurisdictions being co-ordinated and managed by our UK team. We simultaneously advised on a multitude of business separation, ongoing product supply agreements and IP licences for the European business to continue operating after being removed from the Apotex group.

Colin McCall
Simon Cohen
Tasmina Goraya, PhD
Jason Rawkins
Simon Jupp
Bart Hunnekens
Roos Seesing

Simon's news & insights

View Simon's insights
UPC
Click here to find out more
Patents & innovation

LIVE STREAM - The UPC: How to use it, not use it and some problems

17 November 2022

by multiple authors

Glass.Mapper.Sc.Fields.Image?.Alt
Patents & innovation

Cementing our position as expert international IP lawyers at the MIP EMEA IP Awards 2021

31 March 2021

by Simon Cohen and Jörg Wimmers, LL.M. (NYU)

Click here to find out more
Glass.Mapper.Sc.Fields.Image?.Alt
Life sciences & healthcare

Paul England and Simon Cohen launch new life sciences IP guide

23 March 2021

by Dr Paul England and Simon Cohen

Click here to find out more
View Simon's insights

Related news & insights

office building facade
Real estate & construction

The Procurement Act 2023: life sciences and procurement

21 May 2025
Briefing

by Matt Evans and Nicholas Vollers

Click here to find out more
Patents & innovation

Episode 9 - Using expert evidence in the UPC

19 May 2025

by multiple authors

Click here to find out more
People waiting
Brands & advertising

UK to maintain current exhaustion of rights regime

15 May 2025
Quick read

by Louise Popple

Click here to find out more
/Taylor Wessing/Images/Search Result Thumbnails/Insights News and Event/Locations/France/AdobeStock_44592598 place Vendome
Patents & innovation

Taylor Wessing strengthens pan-European patent law offering with new team in Paris

7 May 2025

by multiple authors

Click here to find out more
Patents & innovation

Episode 8 - Confidentiality protection and transparency in the UPC

1 May 2025

by multiple authors

Click here to find out more
DNA helix
Life sciences & healthcare

Updated post-market surveillance (PMS) rules for medical devices in the UK: differences from the EU regulations

1 May 2025
In-depth analysis

by Alison Dennis and Alice Matthews

Click here to find out more
Close-Up Of Wooden Hammer And Gavel
UPC

The UPC: The new forum defines its jurisdictional boundaries

30 April 2025
In-depth analysis

by multiple authors

Click here to find out more
Suspension bridge vanishing point
Israel group

Recognised once again as an elite law firm in the Israeli market

28 April 2025

by Josef Fuss

Click here to find out more
Patent Perspectives Quick Listens
Patents & innovation

Episode 7 - Obtaining documentary evidence in the UPC - a look at Rule 190 of the Rules of Procedure

15 April 2025

by multiple authors

Click here to find out more
Leadership Concepts
Careers

Announcing 20 senior promotions for 2025, including 10 to partnership

9 April 2025

by Shane Gleghorn and Dr. Oliver Bertram

Click here to find out more
View all insights

Related people

UK
Global
Nigel Stoate

Nigel Stoate

Partner

London
+44 20 7300 4783
Email me
View profile
Matthew Royle

Matthew Royle, Ph.D.

Partner

London
+44 20 7300 4608
Email me
View profile
Chris Thornham

Chris Thornham

Partner

London
+44 20 7300 4817
Email me
View profile
Full team
Nigel Stoate

Nigel Stoate

Partner

London
+44 20 7300 4783
Email me
View profile
Dr. Christian Lederer

Dr. Christian Lederer

Partner

Munich
+49 89 21038-0
Email me
View profile
Wim Maas

Dr. Wim Maas

Partner

Amsterdam
Eindhoven
+31 6 3175 2962
Email me
View profile
Matthew Royle

Matthew Royle, Ph.D.

Partner

London
+44 20 7300 4608
Email me
View profile
Chris Thornham

Chris Thornham

Partner

London
+44 20 7300 4817
Email me
View profile
Christoph de Coster, LL.M. (UC Davis); Attorney at

Christoph de Coster, LL.M. (UC Davis)

Of Counsel

Munich
San Francisco
+49 89 21038-0
Email me
View profile
Full team

Meet me at

There are no upcoming events

See all events
Subscribe to our latest insights
  • About us
  • Campaigns and online tools
  • News
  • People
  • Expertise
  • Locations
  • Insights
  • Events
  • Media centre
  • Contact
  • Careers
  • Alumni
  • Data protection & privacy policy
  • Cookie policy
  • Legal and regulatory information
  • Regulatory information on costs
  • Complaints procedure for clients
  • Terms of use
  • Anti-slavery statement
  • Environmental
  • Scam emails

© Taylor Wessing